Innate Pharma S.A. (IPHA) Financials

IPHA Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 216.4 million 153.5 million
2023-03-31 226.6 million 167.5 million
2022-12-31 213.6 million 151.5 million
2022-09-30 203.9 million 150.8 million

IPHA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -12.8 million 761677
2023-03-31 -22.8 million 900891
2022-12-31 -6.3 million 751757
2022-09-30 -10.0 million 810648

IPHA Net Income

No data available :(

IPHA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 96.7 million - -
2023-03-31 110.6 million - -
2022-12-31 95.4 million - 2.2 million
2022-09-30 99.5 million - -

IPHA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 91.1 million
2023-03-31 87.4 million
2022-12-31 89.9 million
2022-09-30 78.0 million

IPHA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 339248 30.9 million 4.9 million 77200
2023-03-31 765185 27.4 million 5.5 million 84475
2022-12-31 165805 16.9 million 4.8 million 76195
2022-09-30 56397 13.1 million 5.0 million 76013

IPHA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 38.4 million 17.1 million
2023-03-31 9.1 million 14.6 million
2022-12-31 21.6 million 16.9 million
2022-09-30 5.9 million 13.1 million

IPHA

Price: $2.57

52 week price:
1.81
3.57

Earnings Per Share: -0.10 USD

P/E Ratio: -3.06

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 6529

Market Capitalization: 205.8 million

Links: